BioCentury
ARTICLE | Clinical News

SCH 900795: Phase Ib started

October 19, 2009 7:00 AM UTC

Schering-Plough began a double-blind, placebo-controlled, Belgian Phase Ib trial to evaluate intranasal SCH 900795 in 140 healthy adults ages 50 and up. BioDiem granted rights for its LAIV technology ...